Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05311956 · ClinicalTrials.gov registry record · NA

Pain Reduction Using NEurostimulation Study

A NA study of Chronic Pain and End-Stage Kidney Disease, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
2
Study locations

NCT05311956 is a NA study of Chronic Pain and End-Stage Kidney Disease that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 125 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05311956, a NA study of Chronic Pain and End-Stage Kidney Disease, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
2
Study locations

Study Summary

This is a 4-year project to see if a small battery-powered, device attached to a headband, that sits on the skin surface and delivers what is a hardly noticeable level of electrical stimulation can reduce pain in patients who receive hemodialysis on an ongoing basis.

Interventions

  • DEVICE Sham tDCS
  • DEVICE Active tDCS

Study Locations (2)

New York

  • The Rogosin Institute - New York
  • NewYork-Presbyterian - Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2022-10-24
Est. Completion 2027-12-31
Phase NA

What the Registry Record Tells You About NCT05311956

The ClinicalTrials.gov registry entry for NCT05311956 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Sham tDCS is the first listed.

NCT05311956 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05311956 about?

NCT05311956 is a clinical study titled "Pain Reduction Using NEurostimulation Study". This is a 4-year project to see if a small battery-powered, device attached to a headband, that sits on the skin surface and delivers what is a hardly noticeable level of electrical stimulation can reduce pain in patients who receive hemodialysis on an ongoing basis.

What is the current status of trial NCT05311956?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2022-10-24. Estimated completion is 2027-12-31.

What conditions does trial NCT05311956 study?

This clinical trial studies the following conditions: Chronic Pain, End-Stage Kidney Disease.

What interventions are being tested in trial NCT05311956?

The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE).

Who is sponsoring clinical trial NCT05311956?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05311956 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.